These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25854612)

  • 41. Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis.
    Roger SD; Kolmakova E; Fung M; Malecki R; Vinhas J; Dellanna F; Thomas M; Manamley N; Ferenczi S
    Nephrology (Carlton); 2014 May; 19(5):266-74. PubMed ID: 24506498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
    Webb L; Gilg J; Wilkie M
    Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anemia Evaluation and Erythropoietin Dose Requirement Among Hemodialysis Patients: a Multicenter Study.
    Nafar M; Samavat S; Khoshdel A; Alipour-Abedi B
    Iran J Kidney Dis; 2017 Jan; 11(1):56-65. PubMed ID: 28174354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project.
    Frankenfield DL; Neu AM; Warady BA; Fivush BA; Johnson CA; Brem AS
    Kidney Int; 2003 Sep; 64(3):1120-4. PubMed ID: 12911565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemoglobin variability in anemia of chronic kidney disease.
    Kalantar-Zadeh K; Aronoff GR
    J Am Soc Nephrol; 2009 Mar; 20(3):479-87. PubMed ID: 19211716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients.
    Kuragano T; Matsumura O; Matsuda A; Hara T; Kiyomoto H; Murata T; Kitamura K; Fujimoto S; Hase H; Joki N; Fukatsu A; Inoue T; Itakura I; Nakanishi T
    Kidney Int; 2014 Oct; 86(4):845-54. PubMed ID: 24759150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-Line(®) during hemodialysis.
    Sugano N; Yokoyama K; Kato N; Hara Y; Endo S; Mitome J; Kin T; Tokudome G; Kuriyama S; Hosoya T; Yokoo T
    Clin Exp Nephrol; 2014 Dec; 18(6):944-51. PubMed ID: 24519373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Long-acting erythropoetin efficacy in the treatment of nephrogenic anemia in patients with chronic kidney disease during predialysis stage].
    Milovanov IuS; Milovanova LIu
    Ter Arkh; 2012; 84(6):48-52. PubMed ID: 22997919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peginesatide in patients with anemia undergoing hemodialysis.
    Fishbane S; Schiller B; Locatelli F; Covic AC; Provenzano R; Wiecek A; Levin NW; Kaplan M; Macdougall IC; Francisco C; Mayo MR; Polu KR; Duliege AM; Besarab A;
    N Engl J Med; 2013 Jan; 368(4):307-19. PubMed ID: 23343061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study.
    Martínez-Castelao A; Cases A; Carballada AT; Iranzo JT; Bronsoms J; Vallès-Prats M; Monserrat DT; Jimenez EM;
    Nefrologia; 2015; 35(2):179-88. PubMed ID: 26300512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.
    Foley RN; Curtis BM; Parfrey PS
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1669-75. PubMed ID: 18922988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Predictors of response to the CERA in chronic hemodialysis treatment-naive by erythropoiesis-stimulating agent].
    Ezziani M; Najdi A; Mikou S; Hanin H; Arrayhani M; Houssaini TS
    Pan Afr Med J; 2015; 20():331. PubMed ID: 26175821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous noninvasive hemoglobin monitor from pulse ox: ready for prime time?
    Joseph B; Hadjizacharia P; Aziz H; Snyder K; Wynne J; Kulvatunyou N; Tang A; O'Keeffe T; Latifi R; Friese R; Rhee P
    World J Surg; 2013 Mar; 37(3):525-9. PubMed ID: 23196342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. UK Renal Registry 16th annual report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses.
    Rao A; Gilg J; Williams A
    Nephron Clin Pract; 2013; 125(1-4):183-208. PubMed ID: 24662174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis.
    Zaher MM; Abdel-Salam M; Abdel-Salam R; Sabour R; Morsy AA; Gamal D
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):233-40. PubMed ID: 26997375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hemoglobin variability in patients with chronic renal insuffiency].
    Deray G
    Nephrol Ther; 2008 Dec; 4(7):549-52. PubMed ID: 19004677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease.
    Cianciaruso B; Ravani P; Barrett BJ; Levin A;
    J Nephrol; 2008; 21(6):861-70. PubMed ID: 19034870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anemia management in chronic kidney disease: bursting the hemoglobin bubble.
    Weiner DE; Miskulin DC
    Ann Intern Med; 2010 Jul; 153(1):53-5. PubMed ID: 20439567
    [No Abstract]   [Full Text] [Related]  

  • 60. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD.
    Levin A; Djurdjev O; Thompson C; Barrett B; Ethier J; Carlisle E; Barre P; Magner P; Muirhead N; Tobe S; Tam P; Wadgymar JA; Kappel J; Holland D; Pichette V; Shoker A; Soltys G; Verrelli M; Singer J
    Am J Kidney Dis; 2005 Nov; 46(5):799-811. PubMed ID: 16253719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.